Both contain tirzepatide as the active ingredient
For someone looking to lose 10-15 lb for aesthetic reasons, the incremental efficacy gain over Tirzepatide or even Semaglutide may not justify the research-grade sourcing process
Commercial launch prices: projected $1,000$1,500/month before discounts Compounded versions: $200$600/month, varies by dose and supplier Starting or sub-clinical doses are less than $100 per month, sometimes below $50
Researchers working with subjects outside this profile should account for several population-specific considerations that affect how the retatrutide escalation schedule performs and how outcomes should be interpreted
Practical considerations include cost and route of administration, as most formulations are injectable, although oral preparations are emerging
Broader weight loss programs often report about 20-32 pounds lost by 8-12 weeks